Here's the live share price of Bliss GVS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | 3.13 | 11.05 | 24.18 | 74.95 | 126.84 | 56.80 | 20.67 |
| Sun Pharmaceutical Industries | 1.96 | 12.84 | 9.86 | 5.49 | 8.79 | 26.67 | 21.76 |
| Divi's Laboratories | 4.16 | 10.16 | 9.95 | 7.22 | 5.10 | 30.72 | 11.37 |
| Torrent Pharmaceuticals | 1.76 | 6.42 | 5.56 | 19.50 | 34.95 | 38.89 | 26.49 |
| Cipla | 9.13 | 14.74 | 6.09 | -7.62 | -5.48 | 15.46 | 9.30 |
| Dr. Reddy's Laboratories | 5.03 | 8.25 | 4.24 | 6.71 | 9.45 | 14.97 | 4.96 |
| Lupin | 1.80 | -1.81 | 2.61 | 12.91 | 12.70 | 43.47 | 13.62 |
| Zydus Lifesciences | 9.48 | 8.82 | 12.93 | 9.52 | 11.80 | 27.27 | 10.63 |
| Mankind Pharma | 4.21 | 15.58 | 21.59 | 11.44 | -3.23 | 23.01 | 11.71 |
| Aurobindo Pharma | 1.80 | 10.80 | 28.89 | 22.91 | 25.65 | 36.99 | 8.29 |
| Laurus Labs | 6.23 | 19.40 | 32.09 | 36.60 | 121.72 | 62.82 | 22.64 |
| Biocon | 6.93 | 19.94 | 12.51 | 4.92 | 25.90 | 21.16 | 2.16 |
| Glenmark Pharmaceuticals | 6.85 | 8.09 | 19.30 | 30.96 | 67.63 | 56.88 | 31.43 |
| Alkem Laboratories | -0.59 | -2.94 | 1.76 | -4.61 | 2.76 | 18.43 | 12.99 |
| Abbott India | 3.50 | 8.84 | 5.50 | -5.88 | -9.27 | 10.06 | 11.66 |
| Anthem Biosciences | -2.04 | 8.33 | 12.74 | 21.94 | 7.35 | 2.39 | 1.43 |
| Ipca Laboratories | 9.27 | 12.50 | 12.80 | 14.25 | 14.95 | 34.77 | 8.65 |
| Ajanta Pharma | 5.55 | 17.38 | 10.25 | 29.67 | 23.96 | 35.93 | 20.13 |
| GlaxoSmithKline Pharmaceuticals | -2.36 | -1.72 | -7.03 | -5.09 | -15.24 | 22.87 | 10.07 |
| Gland Pharma | 20.12 | 25.32 | 22.46 | 26.92 | 51.52 | 28.06 | -7.56 |
Source: Dion Global
Over the last one year, Bliss GVS Pharma has gained 126.84% compared to peers like Sun Pharmaceutical Industries (8.79%), Divi's Laboratories (5.10%), Torrent Pharmaceuticals (34.95%). From a 5 year perspective, Bliss GVS Pharma has outperformed peers relative to Sun Pharmaceutical Industries (21.76%) and Divi's Laboratories (11.37%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 278.22 | 278.78 |
| 10 | 274.39 | 275.45 |
| 20 | 270.33 | 268.49 |
| 50 | 242.41 | 247.33 |
| 100 | 213.01 | 222.85 |
| 200 | 185.72 | 196.38 |
Source: Dion Global
In the latest quarter, Bliss GVS Pharma remained same as its previous close in promoter holding, while DII stake decreased to 5.04%, FII holding fell to 10.45%, and public shareholding moved up to 49.15% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| May 13, 2026, 04:30 AM IST IST | Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| May 13, 2026, 04:21 AM IST IST | Bliss GVS Pharma - Corporate Action-Board approves Dividend |
| May 13, 2026, 04:15 AM IST IST | Bliss GVS Pharma - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019 |
| May 13, 2026, 04:02 AM IST IST | Bliss GVS Pharma - Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 |
| May 13, 2026, 03:48 AM IST IST | Bliss GVS Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, May 12, 2026 |
Source: Dion Global
Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 729.81 Cr. and Equity Capital is Rs. 10.58 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bliss GVS Pharma is ₹281.40 as on May 19, 2026.
The Bliss GVS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Bliss GVS Pharma is ₹2,976.90 Cr as on May 19, 2026.
Today’s highest and lowest price of Bliss GVS Pharma are ₹296.85 and ₹279.60.
The 52-week high/low is the highest and lowest price at which Bliss GVS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bliss GVS Pharma is ₹293.15 and 52-week low of Bliss GVS Pharma is ₹117.20 as on May 19, 2026.
The Bliss GVS Pharma has shown returns of -1.83% over the past day, 11.05% for the past month, 24.18% over 3 months, 126.84% over 1 year, 56.8% across 3 years, and 20.67% over 5 years.
P/E ratio of and PB ratio of Bliss GVS Pharma are 23.05 and 2.57 on May 19, 2026. While the company gives a dividend yield of 0.53 per annum.
Source: Dion Global